A significant portion of SC adults face obesity, the most recent data shows. Here are the 10 counties where rates are highest.

BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...

Excess youth overweight and obesity remained highly prevalent in the United States in 2024, according to a new study.

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

Novo Nordisk is slashing the list prices of its flagship weight-loss and diabetes drugs, including Wegovy and Ozempic, by up ...

Women’s heart health is heading toward a crisis, with nearly 60% projected to have cardiovascular disease by 2050.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

Allurion saw its shares jump roughly 60% on Monday, Feb. 23, as the FDA signed off on the medtech’s premarket approval ...

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.

NEW HAVEN, CT, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- Yale Associate Research Scientist Investigates ...